IPO

According to an analyst note from Leerink Swann, Bruker's planned IPO for its Energy and Supercon Technologies subsidiary would allow Bruker to concentrate on its core life science business.

The company still intends to move forward with its IPO originally announced two years ago but can't say when that will happen.

The bioinformatics firm plans to list on the Ace Market of Bursa Malaysia and hopes to raise up to $5.9 million.

The firm has raised around $370 million since its inception, and is now seeking to go public in an offering that could potentially bring in $200 million.

The sequencing service company hopes to raise as much as $86.3 million from its offering.

GenMark Shares Began Trading on the Nasdaq on May 28.

The company had initially said it expected a price range of between $8 and $10, but the IPO will now go off at $6 per share.

The company said that a UK court today agreed to sanction its plan to float in the US, conditional upon the execution of the Underwriter Agreement by Osmetech and the underwriters before 7 a.m. BST, Friday.